Paul Bolin

Summary

Affiliation: East Carolina University
Country: USA

Publications

  1. ncbi Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients
    Paul Bolin
    Division of Nephrology and Hypertension, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA
    Transplantation 84:1443-51. 2007
  2. ncbi The role of nephrologists in coordinating care with primary care practitioners
    Paul Bolin
    Division of Nephrology, Brody School of Medicine at East Carolina University, USA
    N C Med J 69:219-20. 2008
  3. ncbi Mycophenolic acid in kidney transplant patients with diabetes mellitus: does the formulation matter?
    Paul Bolin
    Division of Nephrology and Hypertension, Brody School of Medicine, East Carolina University, NC, USA
    Transplant Rev (Orlando) 25:117-23. 2011
  4. ncbi Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study
    Anthony J Langone
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA
    Transplantation 91:470-8. 2011
  5. ncbi Platelet adhesion testing may predict early hemodialysis arteriovenous graft and fistula failure in end-stage renal disease patients
    Samer E ElChoufani
    Department of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27834, USA
    Clin Appl Thromb Hemost 14:399-409. 2008
  6. ncbi Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results
    Paul Bolin
    Division of Nephrology, Department of Medicine, East Carolina University, Greenville, NC, USA
    Transplantation 86:88-95. 2008

Detail Information

Publications6

  1. ncbi Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients
    Paul Bolin
    Division of Nephrology and Hypertension, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA
    Transplantation 84:1443-51. 2007
    ..However, data are lacking concerning the sustained effect of conversion over time, and the potential impact of concomitant calcineurin inhibitor...
  2. ncbi The role of nephrologists in coordinating care with primary care practitioners
    Paul Bolin
    Division of Nephrology, Brody School of Medicine at East Carolina University, USA
    N C Med J 69:219-20. 2008
  3. ncbi Mycophenolic acid in kidney transplant patients with diabetes mellitus: does the formulation matter?
    Paul Bolin
    Division of Nephrology and Hypertension, Brody School of Medicine, East Carolina University, NC, USA
    Transplant Rev (Orlando) 25:117-23. 2011
    ..Comparative trials to evaluate the GI symptom burden and maximum achieved MPA dosing using the EC-MPS and MMF formulations in de novo and maintenance diabetic kidney transplant recipients are merited...
  4. ncbi Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study
    Anthony J Langone
    Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA
    Transplantation 91:470-8. 2011
    ..Using a randomized design, this study evaluated changes in GI symptoms and health-related quality of life in patients converted from MMF to EC-MPS versus patients who continued with MMF-based treatment...
  5. ncbi Platelet adhesion testing may predict early hemodialysis arteriovenous graft and fistula failure in end-stage renal disease patients
    Samer E ElChoufani
    Department of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27834, USA
    Clin Appl Thromb Hemost 14:399-409. 2008
    ..Collagen-induced platelet aggregation reflected a significantly higher response in those with shortened access survival. These findings may have significant clinical implications for risk assessment and prevention of VAT...
  6. ncbi Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results
    Paul Bolin
    Division of Nephrology, Department of Medicine, East Carolina University, Greenville, NC, USA
    Transplantation 86:88-95. 2008
    ..The determination of optimal tacrolimus (TAC) trough levels is needed to prevent adverse effects of calcineurin inhibitors...